Elkem to Sell Majority of Silicones Division to Bluestar

Key highlights
  • Elkem to sell majority of Silicones division to Bluestar, settled by redeeming 338,338,536 shares.
  • Transaction requires shareholder approval at EGM on 9 March 2026.
  • Folketrygdfondet and others pre-committed support and underwritten NOK 1,500 million equity raise.
  • Transaction expected to close by May 2026, pending approvals.

Transaction Overview

Elkem ASA has agreed to sell the majority of its Silicones division to Bluestar. The transaction will be settled through the redemption of Bluestar's 338,338,536 shares in Elkem, representing 52.9% of the company. No cash payments will be involved in the settlement.

Strategic Goals

This transaction aligns with the long-term strategic goals of both Elkem and Bluestar, focusing on operations and ownership. Bluestar, as Elkem's largest shareholder and former owner of parts of the Silicones assets, aims to strengthen its position in the silicones value chain.

Approval and Support

The transaction is subject to approval by Elkem's shareholders at an extraordinary general meeting (EGM) scheduled for 9 March 2026. It also requires waivers and approvals from lenders and other customary conditions. Key shareholders, including Folketrygdfondet, Must Invest, DNB Asset Management, Nordea Investment Management, and Perestroika, have pre-committed their support for the transaction and underwritten a NOK 1,500 million equity capital raise.

Timeline

The transaction is expected to close by May 2026, pending the satisfaction or waiver of all closing conditions. Bluestar is entitled to vote on the share redemption and has committed to supporting it, with shareholders holding 67% of the eligible share capital also agreeing to vote in favor.

Source: Elkem

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

30 April 2026
Elkem completes sale of Silicones division to Bluestar and redeems Bluestar shares

Registered share capital is NOK 1,505,514,210 (301,102,842 shares, NOK 5 par). Board and Nomination Committee changes took effect; seller no longer represented.

8 April 2026
Elkem's Helge Aasen to step down as CEO, nominated as board chairman

Nomination committee’s proposals take effect after completion of the majority Silicones sale to Bluestar; the current CEO will stay on until a successor is in place. AGM 30 Apr 2026.

11 March 2026
Elkem Restructures and Cuts Costs to Boost Competitiveness

Elkem introduces a new structure, reduces workforce by 300, and cuts costs by NOK 1.9 billion to enhance profitability amid market challenges.

10 July 2026
Elkem Q2 2026 results: cost reductions and balance‑sheet strengthening

EBITDA fell on weak silicon prices; raised NOK 1.8bn, refinanced EUR 1bn facility and obtained NOK 750m NIB loan; Elkem Iceland reclassified as discontinued.

2 July 2026
Elkem appoints Dag Teigland as CEO; Helge Aasen to chair the board

Leadership change effective 3 August 2026; incoming CEO returns with industrial and investment experience and prior Elkem roles; outgoing CEO moves to board chair after 17 years.